Description
A selective ROCK inhibitor (IC50s = 1.6 and 6 nM for ROCK-I and ROCK-II, respectively); blocks the generation of inflammatory cytokines in LPS-stimulated monocytes and induces vasorelaxation in preconstricted rat aorta (IC50 = 35 nM)
Formal name: N-[3-[[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-1H-imidazo[4,5-c]pyridin-6-yl]oxy]phenyl]-4-[2-(4-morpholinyl)ethoxy]-benzamide
Synonyms: GSK269962A|GSK269962B
Molecular weight: 570.6
CAS: 850664-21-0
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|ROCK||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cardiovascular System|Cardiovascular Diseases|Hypertension||Research Area|Cardiovascular System|Vasculature|Vasodilation||Research Area|Immunology & Inflammation|Innate Immunity